Tigran Makunts

498 total citations
21 papers, 332 citations indexed

About

Tigran Makunts is a scholar working on Pharmacology, Oncology and Clinical Psychology. According to data from OpenAlex, Tigran Makunts has authored 21 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Oncology and 4 papers in Clinical Psychology. Recurrent topics in Tigran Makunts's work include Gastroesophageal reflux and treatments (4 papers), Psychedelics and Drug Studies (4 papers) and Forensic Toxicology and Drug Analysis (4 papers). Tigran Makunts is often cited by papers focused on Gastroesophageal reflux and treatments (4 papers), Psychedelics and Drug Studies (4 papers) and Forensic Toxicology and Drug Analysis (4 papers). Tigran Makunts collaborates with scholars based in United States, Germany and Armenia. Tigran Makunts's co-authors include Ruben Abagyan, Isaac Cohen, Rabia S. Atayee, Kelly C. Lee, Linda Awdishu, M. Axel Wollmer, Keith Burkhart, Peter P. Lee, Kelan Thomas and Ila M. Saunders and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Tigran Makunts

20 papers receiving 325 citations

Peers

Tigran Makunts
Patrick Martin United States
Cira Antonietta Forte Italy
Yeong Chan Lee South Korea
Kenneth Clark United States
Liying Miao China
Takenori Sakai Japan
Alberto Espino Chile
Irene Caruso Italy
K. Huibregtse United States
Andrea Grandi Italy
Patrick Martin United States
Tigran Makunts
Citations per year, relative to Tigran Makunts Tigran Makunts (= 1×) peers Patrick Martin

Countries citing papers authored by Tigran Makunts

Since Specialization
Citations

This map shows the geographic impact of Tigran Makunts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tigran Makunts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tigran Makunts more than expected).

Fields of papers citing papers by Tigran Makunts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tigran Makunts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tigran Makunts. The network helps show where Tigran Makunts may publish in the future.

Co-authorship network of co-authors of Tigran Makunts

This figure shows the co-authorship network connecting the top 25 collaborators of Tigran Makunts. A scholar is included among the top collaborators of Tigran Makunts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tigran Makunts. Tigran Makunts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Makunts, Tigran, et al.. (2023). Depression Events Associated with Proton-Pump Inhibitors in Postmarketing Drug Surveillance Data. SHILAP Revista de lepidopterología. 2(3). 272–282. 2 indexed citations
5.
Makunts, Tigran, et al.. (2023). Concomitant medications associated with ischemic, hypertensive, and arrhythmic events in MDMA users in FDA adverse event reporting system. Frontiers in Psychiatry. 14. 1149766–1149766. 3 indexed citations
6.
Makunts, Tigran, et al.. (2023). Anti-TNF-α therapy induced psoriasis in rheumatoid arthritis patients according to FDA postmarketing surveillance data. Scientific Reports. 13(1). 10448–10448. 6 indexed citations
7.
Makunts, Tigran, et al.. (2022). Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database. Frontiers in Psychiatry. 12. 824288–824288. 10 indexed citations
8.
Makunts, Tigran, Keith Burkhart, Ruben Abagyan, & Peter P. Lee. (2022). Retrospective analysis of clinical trial safety data for pembrolizumab reveals the effect of co-occurring infections on immune-related adverse events. PLoS ONE. 17(2). e0263402–e0263402. 5 indexed citations
9.
Cohen, Isaac, Tigran Makunts, Ruben Abagyan, & Kelan Thomas. (2021). Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database. Scientific Reports. 11(1). 5997–5997. 16 indexed citations
10.
Makunts, Tigran, et al.. (2021). Common osteoporosis drug associated with increased rates of depression and anxiety. Scientific Reports. 11(1). 23956–23956. 22 indexed citations
11.
Wollmer, M. Axel, Tigran Makunts, Tillmann H. C. Krüger, & Ruben Abagyan. (2021). Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety. Scientific Reports. 11(1). 24173–24173. 15 indexed citations
12.
Makunts, Tigran, Ila M. Saunders, Isaac Cohen, et al.. (2021). Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data. Scientific Reports. 11(1). 17324–17324. 35 indexed citations
13.
Makunts, Tigran, et al.. (2020). How can proton pump inhibitors damage central and peripheral nervous systems?. Neural Regeneration Research. 15(11). 2041–2041. 6 indexed citations
14.
Makunts, Tigran, M. Axel Wollmer, & Ruben Abagyan. (2020). Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites. Scientific Reports. 10(1). 12851–12851. 19 indexed citations
15.
Cohen, Isaac, et al.. (2020). Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports. Scientific Reports. 10(1). 19199–19199. 20 indexed citations
16.
Makunts, Tigran, et al.. (2019). Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids. Scientific Reports. 9(1). 12490–12490. 32 indexed citations
17.
Makunts, Tigran, Isaac Cohen, Linda Awdishu, & Ruben Abagyan. (2019). Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis. Scientific Reports. 9(1). 2282–2282. 49 indexed citations
18.
Makunts, Tigran, et al.. (2019). Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory. Scientific Reports. 9(1). 17280–17280. 46 indexed citations
19.
Makunts, Tigran, Isaac Cohen, Kelly C. Lee, & Ruben Abagyan. (2018). Population scale retrospective analysis reveals distinctive antidepressant and anxiolytic effects of diclofenac, ketoprofen and naproxen in patients with pain. PLoS ONE. 13(4). e0195521–e0195521. 20 indexed citations
20.
Cohen, Isaac, Tigran Makunts, Rabia S. Atayee, & Ruben Abagyan. (2017). Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications. Scientific Reports. 7(1). 1450–1450. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick Martin Breakdown of academic impact, for papers by Cira Antonietta Forte Breakdown of academic impact, for papers by Yeong Chan Lee Breakdown of academic impact, for papers by Kenneth Clark Breakdown of academic impact, for papers by Liying Miao Breakdown of academic impact, for papers by Takenori Sakai Breakdown of academic impact, for papers by Alberto Espino Breakdown of academic impact, for papers by Irene Caruso Breakdown of academic impact, for papers by K. Huibregtse Breakdown of academic impact, for papers by Andrea Grandi
Rankless by CCL
2026